At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 9 enrolled
Drug / intervention
r-tPA +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism
In Brief
A Phase 1 clinical trial evaluating r-tPA and The Bashir™ Endovascular Catheter for Pulmonary Embolism. Completed, enrolled 9 participants across 5 sites.
Detailed Summary
The Bashir™ Endovascular Catheter is a device intended for the localized infusion of therapeutic agents into the pulmonary artery and peripheral vasculature.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20192020202120222023202420252026
Enrollment StartMar 2019
First PostedApr 2019
Primary CompletionDec 2019
Study CompletionJan 2020
TodayJul 2026
First PostedApr 25, 2019
Enrollment StartMar 14, 2019
Primary CompletionDec 19, 2019
Study CompletionJan 23, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.2 years ago
Interventions
r-tPAdrug
Pulse spray and infusion
The Bashir™ Endovascular Catheterdevice
The Bashir™ Endovascular Catheter is a device intended for the localized infusion of therapeutic agents into the pulmonary artery and peripheral vasculature.